Asthika Goonewardene
Stock Analyst at Truist Securities
(1.31)
# 3,494
Out of 4,893 analysts
100
Total ratings
37.08%
Success rate
-13.37%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Asthika Goonewardene
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GMAB Genmab | Maintains: Buy | $45 → $46 | $21.86 | +110.43% | 15 | Jul 8, 2025 | |
| EXEL Exelixis | Reiterates: Buy | $43 → $55 | $45.17 | +21.76% | 9 | Jun 23, 2025 | |
| IGMS IGM Biosciences | Maintains: Hold | $2 → $1 | $1.36 | -26.47% | 9 | Jun 11, 2025 | |
| BNTX BioNTech SE | Reiterates: Buy | $151 → $155 | $113.92 | +36.06% | 3 | Jun 3, 2025 | |
| MRSN Mersana Therapeutics | Maintains: Buy | $9 → $10 | $0.38 | +2,531.58% | 4 | May 16, 2025 | |
| LEGN Legend Biotech | Maintains: Buy | $88 → $71 | $39.71 | +78.80% | 2 | May 14, 2025 | |
| ALLO Allogene Therapeutics | Maintains: Buy | $14 → $10 | $1.26 | +693.65% | 7 | May 14, 2025 | |
| AUTL Autolus Therapeutics | Maintains: Buy | $11 → $10 | $2.48 | +303.23% | 4 | Apr 1, 2025 | |
| IOVA Iovance Biotherapeutics | Maintains: Buy | $25 → $15 | $1.93 | +677.20% | 6 | Mar 3, 2025 | |
| CRGX CARGO Therapeutics | Downgrades: Hold | $32 → $7 | $4.59 | +52.67% | 3 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $35 | $25.88 | +35.24% | 1 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $87 → $136 | $68.85 | +97.53% | 5 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $83 → $97 | $114.54 | -15.31% | 1 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $15 | $0.82 | +1,734.19% | 6 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $44 | $9.54 | +361.22% | 1 | Jun 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $69 → $88 | $55.11 | +59.68% | 2 | Jun 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $4 | $1.69 | +136.69% | 5 | May 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 | $1.74 | +991.95% | 3 | May 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $1.22 | +3,178.69% | 4 | Sep 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $27 | $0.74 | +3,549.64% | 2 | Sep 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Hold | $120 | $26.84 | +347.09% | 1 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $100 → $60 | $2.14 | +2,703.74% | 3 | Aug 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $15 | $0.47 | +3,103.76% | 4 | Aug 23, 2022 |
Genmab
Jul 8, 2025
Maintains: Buy
Price Target: $45 → $46
Current: $21.86
Upside: +110.43%
Exelixis
Jun 23, 2025
Reiterates: Buy
Price Target: $43 → $55
Current: $45.17
Upside: +21.76%
IGM Biosciences
Jun 11, 2025
Maintains: Hold
Price Target: $2 → $1
Current: $1.36
Upside: -26.47%
BioNTech SE
Jun 3, 2025
Reiterates: Buy
Price Target: $151 → $155
Current: $113.92
Upside: +36.06%
Mersana Therapeutics
May 16, 2025
Maintains: Buy
Price Target: $9 → $10
Current: $0.38
Upside: +2,531.58%
Legend Biotech
May 14, 2025
Maintains: Buy
Price Target: $88 → $71
Current: $39.71
Upside: +78.80%
Allogene Therapeutics
May 14, 2025
Maintains: Buy
Price Target: $14 → $10
Current: $1.26
Upside: +693.65%
Autolus Therapeutics
Apr 1, 2025
Maintains: Buy
Price Target: $11 → $10
Current: $2.48
Upside: +303.23%
Iovance Biotherapeutics
Mar 3, 2025
Maintains: Buy
Price Target: $25 → $15
Current: $1.93
Upside: +677.20%
CARGO Therapeutics
Jan 30, 2025
Downgrades: Hold
Price Target: $32 → $7
Current: $4.59
Upside: +52.67%
Jan 8, 2025
Initiates: Buy
Price Target: $35
Current: $25.88
Upside: +35.24%
Nov 12, 2024
Maintains: Buy
Price Target: $87 → $136
Current: $68.85
Upside: +97.53%
Nov 8, 2024
Maintains: Hold
Price Target: $83 → $97
Current: $114.54
Upside: -15.31%
Aug 16, 2024
Maintains: Buy
Price Target: $18 → $15
Current: $0.82
Upside: +1,734.19%
Jun 24, 2024
Maintains: Buy
Price Target: $50 → $44
Current: $9.54
Upside: +361.22%
Jun 4, 2024
Maintains: Buy
Price Target: $69 → $88
Current: $55.11
Upside: +59.68%
May 21, 2024
Maintains: Buy
Price Target: $5 → $4
Current: $1.69
Upside: +136.69%
May 16, 2024
Maintains: Buy
Price Target: $19
Current: $1.74
Upside: +991.95%
Sep 6, 2023
Reiterates: Buy
Price Target: $40
Current: $1.22
Upside: +3,178.69%
Sep 6, 2023
Reiterates: Buy
Price Target: $27
Current: $0.74
Upside: +3,549.64%
Apr 5, 2023
Reinstates: Hold
Price Target: $120
Current: $26.84
Upside: +347.09%
Aug 23, 2022
Maintains: Hold
Price Target: $100 → $60
Current: $2.14
Upside: +2,703.74%
Aug 23, 2022
Maintains: Buy
Price Target: $19 → $15
Current: $0.47
Upside: +3,103.76%